ライフサイエンスコーパス: case fatality rate

1 in a number of human infections with a high case fatality rate.

2 d outbreaks of a SARS-like illness with high case fatality rate.

3 rates of other serious adverse events or the case fatality rate.

4 to determine trends in annual incidence and case fatality rate.

5 tions, and comorbidity, and carries a higher case fatality rate.

6 or endocardial fibroelastosis quadrupled the case fatality rate.

7 rburg hemorrhagic fever can have a very high case fatality rate.

8 1% of American cancer deaths and have a high case fatality rate.

9 isease onset in the population, and the high case fatality rate.

10 a fatal zoonotic disease with a nearly 100% case fatality rate.

11 e (LD) is a preventable pneumonia with a 30% case fatality rate.

12 rious neuroinvasive disease with up to a 10% case fatality rate.

13 t hospitals probably contributed to the high case-fatality rate.

14 he rapid onset of pulmonary edema and a high case-fatality rate.

15 nfirmed cases have been reported, with a 53% case-fatality rate.

16 that are known to cause infections with high case fatality rates.

17 rus that causes sporadic outbreaks with high case fatality rates.

18 or hospitalization and mortality but similar case fatality rates.

19 (LASV) can cause hemorrhagic fever with high case fatality rates.

20 use human viral hemorrhagic fevers with high case fatality rates.

21 us cause serious disease outbreaks with high case fatality rates.

22 injury is likely to reduce historically high case fatality rates.

23 Age/sex/race-adjusted case-fatality rates.

24 new areas has often been accompanied by high case-fatality rates.

25 measures were population mortality rates and case-fatality rates.

26 ties in screening for cancer and with higher case-fatality rates.

27 Results were standardised to UK case-fatality rates.

28 ng hospitalizations, and hospitalization and case-fatality rates.

29 vention of AMI given declining incidence and case-fatality rates.

30 den of invasive disease with high associated case-fatality rates.

31 ase severity was assessed with four markers: case-fatality rate (1.3%), length of ICU stay (mean, 3.0

32 .8 cases per 100,000 persons with 56 deaths (case fatality rate, 10.7%).

33 100 000 persons per year) with 1116 deaths (case-fatality rate, 11.7%).

34 ially despite a continuous decline in 30-day case fatality rate (12.5% in 1979 to 1989; 6.7% in 2000

35 of diphtheria and 286 diphtheria fatalities (case fatality rate: 13.1%) were reported in Azerbaijan,

36 bclade D having the highest 30-day estimated case-fatality rate (19% vs 3%-14%).

37 total of 7615 cholera cases with 181 deaths (case fatality rate = 2.4%).

38 Pneumococcal meningitis had the highest case fatality rate (21 percent) and in 36 percent of cas

39 Among 6388 RMSF patients, 213 died (annual case-fatality rate, 3.3%; range, 4.9% in 1982 to 1.1% in

40 essing human disease with one of the highest case fatality rates (30 to 50%) of any acute viral disea

41 Overall case-fatality rate (30 days) was higher in patients with

42 atory-confirmed MERS-CoV infection, 93 died (case fatality rate, 36.5%).

43 e 3146 IPD cases and 150 IPD-related deaths (case fatality rate, 4.8%).

44 ll patients with fulminant hepatitis B died (case-fatality rate = 47.6%).

45 The EOD case fatality rate (71%) was higher than in LOD (32%) or

46 Case-fatality rate (8%) and development of sequelae (29%

47 onfirmed and 106 suspected) were identified (case fatality rate, 83 percent); 52 percent of cases wer

48 l MARV infection outbreak in history, with a case-fatality rate (90%) similar to that for Zaire ebola

49 Gastrointestinal bleeding incidence and case-fatality rates account only for age and sex.

50 Clinical outcomes studied included adjusted case fatality rates (aCFR), including the ratio of weeke

51 The main outcome measures were the case-fatality rate adjusted for injury severity, hospita

52 s independently associated with an increased case fatality rate (adjusted subdistribution hazard rati

53 Case fatality rates after all types of blunt injury have

54 Three-year case fatality rates after hospitalized AMI decreased con

55 52% to 2.94%), contrasting with a decreasing case fatality rate among hospitalizations (annual percen

56 We sought to estimate the case fatality rate among hospitalizations or emergency d

57 The incubation period and case fatality rate among patients with EVD in Sierra Leo

58 t this increase was offset by the decreasing case fatality rate among those hospitalized; both inpati

59 Case fatality rates among African children with cerebral

60 Case fatality rates among hospitalized patients diagnose

61 umonia and 42% (95% CI, 18%-59%) in reducing case fatality rates among patients with influenza, using

62 The case-fatality rate among patients aged 18 to 64 years wi

63 The case-fatality rate among the 9 total cases was 22%.

64 usness led to extraordinary attack rates and case-fatality rates among HIV-infected persons.

65 are risk-adjusted complication incidence and case-fatality rates among patients experiencing serious

66 Despite the high case fatality rate and large number of persons at risk o

67 measured associations between the estimated case fatality rate and patients' age and the time from o

68 associated coronavirus (MERS-CoV) cause high case fatality rates and remain major human public health

69 s appears to be low; however, given the high case-fatality rate and the presence of virus in respirat

70 -based therapeutic care substantially reduce case-fatality rates and increase coverage rates.

71 auses the most severe form of HFRS (5 to 15% case-fatality rate) and afflicts tens of thousands of pe

72 ia, coverage of antimalarial drug treatment, case fatality rate, and population distribution accordin

73 easures were incidence rate, mortality rate, case fatality rate, and survival to discharge for patien

74 ls with calibrated parameters for infection, case fatality rates, and vaccine efficacy, basic childho

75 ERS-CoV) infection is associated with a high case-fatality rate, and the potential pandemic spread of

76 stimates, baseline GI bleeding incidence and case-fatality rates, and disutilities associated with as

77 an would be predicted if risk factor levels, case-fatality rates, and event rates in those with and w

78 atal encephalitis infections in humans, with case fatality rates approaching 75%.

79 the most deadly infectious diseases, with a case-fatality rate approaching 100%.

80 Case fatality rates are estimated to be in the 30% range

81 acity, which limits the effect of treatment; case-fatality rates are 20-30% and coverage is commonly

82 differ markedly by region and ethnicity, and case-fatality rates are highest in black men living in i

83 re hemorrhagic fever in humans with reported case fatality rates as high as 90%.

84 avirus causes severe hemorrhagic fever, with case fatality rates as high as 90%.

85 High case-fatality rates, as well as known aerosol infectivit

86 in the incidence, in-hospital and long-term case-fatality rates associated with acute myocardial inf

87 recent and temporal trends in the attack and case-fatality rates associated with AMI from a represent

88 a are available describing the incidence and case-fatality rates associated with HF complicating AMI

89 veness (50,000 dollars/QALY), differences in case fatality rates between low- and high-volume hospita

90 empyema, sepsis, or respiratory disease) and case fatality rates by serotype and age group (5, 5-64,

91 We then created collective surgical case fatality rates by WHO region.

92 estimated the risk of hospital admission and case fatality rate caused by pneumonia in HIV-infected c

93 The case fatality rate (CFR) for children was 48.7%, with Eg

94 idemic areas are continuing to grow, but the case fatality rate (CFR) has steadily decreased.

95 e (CAR), with a "low severity" scenario with case fatality rates (CFR) of 0.05%-0.1%, or a "high seve

96 actors for adverse outcomes, and examined ED case fatality rates (CFR).

97 11] vs 9.9% [964 of 9755]; P < .001) and the case fatality rate ([CFR] 13.7 [469 of 3429] vs 7.6 [134

98 of 659 cases and 68 deaths were identified (case fatality rate [CFR] = 10.3%).

99 olera and 2641 deaths were reported (overall case-fatality rate [CFR], 3.9%), affecting all regions o

100 ith ineffective antimicrobials may result in case fatality rates (CFRs) exceeding 70%(4,5).

101 We analyzed surveillance data and estimated case fatality rates (CFRs).

102 Therefore, we have documented case-fatality rates (CFRs) over a recent 10-year period.

103 The cumulative case fatality rate consistently trended downward, reachi

104 tion, age-adjusted gender- and race-specific case fatality rates declined during 1995-2002.

105 Over a 10-year period, the case-fatality rate declined in patients with severe inju

106 ) and 5.6% (p < .001), respectively, whereas case fatality rate decreased by 1.4% (p < .001).

107 However, case fatality rates decreased during the same study peri

108 ong patients diagnosed with 1 condition, the case-fatality rate decreased in a stepwise fashion acros

109 ngitis, a life-threating disease with a high case fatality rate despite treatment with antibiotics.

110 The case fatality rate did not change significantly: it was

111 ortion of cases with meningococcemia and the case-fatality rate did not change.

112 The case-fatality rate differed significantly between subcla

113 Morbidity and case-fatality rate due to PM remain substantial.

114 ease in humans and other primates, with high case fatality rates during human outbreaks.

115 in was found to be effective in reducing the case-fatality rate, especially among moderately ill pati

116 Based on our model, case fatality rate estimates by subregion ranged from 0.

117 tegy was cost-effective when the hepatitis A case fatality rate exceeded 17% (baseline 2.7%).

118 crude and multivariable-adjusted in-hospital case-fatality rates exhibited a consistent decline betwe

119 ts selected by using perfusion CT, including case-fatality rate, favorable outcome (modified Rankin S

120 ,000 population (p < .001), whereas hospital case fatality rate fell from 45.8% +/- 0.17% to 37.8% +/

121 At Mary Theresa Hospital, case-fatality rates fell from 46% before implementation

122 ith implementation of the WHO guidelines and case-fatality rates fell.

123 ospital precludes adequate assessment of why case-fatality rates fell.

124 the accidental nature of the ingestions, the case fatality rate for pediatric patients is significant

125 The case fatality rate for S.

126 ization and mortality, there is a decreasing case fatality rate for severe sepsis.

127 We then calculated the size-specific cancer case fatality rate for two time periods: a baseline peri

128 a virus causes hemorrhagic fever with a high case fatality rate for which there is no approved therap

129 We examined trends in case fatality rates for all-cause clinical pneumonia and

130 In-hospital case fatality rates for AMI also followed a seasonal pat

131 We validated our model against known case fatality rates for caesarean delivery.

132 Disparities in case fatality rates for heart disease among ethnic group

133 In this study, age-adjusted case fatality rates for hospitalized white and black pat

134 Reductions in short-term case fatality rates for myocardial infarction appear to

135 cine have not led to significant declines in case fatality rates for women when compared to the drama

136 recent advances have not led to declines in case fatality rates for women.

137 The overall case-fatality rate for abortion is less than 1 death per

138 the regional frequency of diagnoses and the case-fatality rate for chronic conditions.

139 The case-fatality rate for first stroke is also higher in Am

140 The overall in-hospital case-fatality rate for patients who developed cardiogeni

141 ulation for relevant age and sex groups) and case-fatality rate for primary acute myocardial infarcti

142 ds (2001-2011) in the incidence and hospital case-fatality rates for patients who developed cardiogen

143 The case-fatality rates for septic shock, STSS, and NF were

144 There is a 30% higher case fatality rate from cancer in psychiatric patients e

145 ough the disease is treatable, reported RMSF case fatality rates from this region are high (7%) compa

146 The overall age-adjusted 30-day case-fatality rate from first stroke was 18%, with a 1-y

147 -adjusted life-year for low-risk people with case-fatality rates from 1998 were 2477 dollars for blac

148 Case-fatality rates have decreased with improvements in

149 ratory illness and is associated with a high case fatality rate; however, the pathogenesis of severe

150 However, case fatality rate in 2012 remained high for children wi

151 ons with this isolate led to a 100% apparent case fatality rate in birds.

152 us cardiopulmonary syndrome (HCPS) has a 35% case fatality rate in Chile and no specific treatment.

153 There was a significantly higher case fatality rate in minorities compared with whites, w

154 The case fatality rate in patients with dengue shock syndrom

155 the highest bacterial meningitis attack and case fatality rate in the world.

156 Crude 30-day, 1-year, and 5-year case fatality rates in 1960 to 1969 and 1990 to 1999 wer

157 Case fatality rates in west Africa were initially greate

158 The case-fatality rate in HEU infants (29% [74/253]) was int

159 cation rates or failure to rescue rates (ie, case-fatality rates in patients with a complication).

160 remic infections, including 7-day and 30-day case-fatality rates, in Finland during 2004-2014 and lin

161 Case-fatality rates increased linearly by age; age was a

162 Although case-fatality rates increased with age, 736 (47%) of 156

163 f age (49.9% male), and we estimate that the case fatality rate is 70.8% (95% confidence interval [CI

164 The high case fatality rate is due in part because most ovarian c

165 enomenon as well as the contributors to high case-fatality rate is a growing public health concern to

166 ly on supportive care, which, given the high case-fatality rate, is not highly effective.

167 ywhere near the current confirmed H5N1 human case-fatality rate, it could endanger the lives of hundr

168 Inpatient trauma case fatality rates may provide an incomplete assessment

169 rose by 35.8% (p < .0001), whereas the crude case fatality rate (number of deaths/number of cases) fe

170 re fewer than 600 in number, with an overall case fatality rate of >50%.

171 xis did not result in death, with an average case fatality rate of 0.3%.

172 a downward trend in mortality, with a 14-day case fatality rate of 1.0% or less in most areas.

173 The case fatality rate of 1182 patients with laboratory-conf

174 th hemorrhagic manifestations and an initial case fatality rate of 12 to 30% was reported.

175 um infection is cerebral malaria (CM) with a case fatality rate of 15-25% in African children despite

176 firmed in Jiangsu and Anhui provinces with a case fatality rate of 16.1%.

177 edicted risk of poor outcome (25%-50% risk): Case Fatality Rate of 21% in the placebo group and 52% i

178 evaluated, 21 died, representing an overall case fatality rate of 30%.

179 d by a coronavirus, is highly lethal, with a case fatality rate of 35 to 40%.

180 ted in 1,791 cases of MERS and 640 deaths (a case fatality rate of 36%).

181 Among these, there were 44 deaths, for a case fatality rate of 5.1%.

182 6903 of whom died, and calculated an overall case fatality rate of 6.6% (95% CI 6.4-6.7).

183 humans and nonhuman primates, with a median case fatality rate of 78.4%.

184 The outbreak had a case fatality rate of 80%.

185 , and some hemorrhagic manifestations with a case fatality rate of about 2 to 15%.

186 96 confirmed cases of SARS and 774 deaths (a case fatality rate of approximately 10%).

187 ike symptoms and multi-organ failure, with a case fatality rate of approximately 36%.

188 respiratory syndrome (MERS), and an initial case fatality rate of more than 40%.

189 no deaths in the exposed group, the overall case fatality rate of the cardiac-NL fetuses in the unex

190 ver in humans and non-human primates, with a case fatality rate of up to 88% in human outbreaks.

191 Recently, case fatality rates of acute pancreatitis have stabilize

192 signated hantavirus pulmonary syndrome, with case fatality rates of around 40%.

193 In the as-treated analysis, case fatality rates of bleeding leading to hospitalizati

194 Case fatality rates of filovirus disease outbreaks are a

195 is the most lethal Ebola virus species, with case fatality rates of up to 90%.

196 m across the United States, where there is a case-fatality rate of 15%-29% in individuals >70 years o

197 ate from first stroke was 18%, with a 1-year case-fatality rate of 32%.

198 Previous studies describe a case-fatality rate of 5%-15% and up to 20% of survivors

199 The case-fatality rate of 9.4% is probably underestimated be

200 It has been suggested that the true case-fatality rate of human H5N1 influenza infection is

201 ardial infarction had two to three times the case-fatality rate of patients in whom acute myocardial

202 The overall case-fatality rate of severe pneumonia was 22%.

203 s caused outbreaks in human populations with case-fatality rates of approximately 36%.

204 mporary trends in the incidence and hospital case-fatality rates of cardiogenic shock in patients hos

205 cant differences in the unadjusted long-term case-fatality rates of discharged hospital survivors ove

206 ges over time in the incidence and long-term case-fatality rates of greater Worcester, Mass, resident

207 In-hospital case-fatality rates of patients with AMI complicated by

208 Case-fatality rates of the African species in man are as

209 rus disease in humans is highly lethal, with case fatality rates ranging from 25 to 90%.

210 ons and encephalitis in Southeast Asia, with case fatality rates ranging from 40% to more than 90%.

211 a severe hemorrhagic fever in humans with a case-fatality rate ranging from 25 to 36%.

212 in humans and nonhuman primates (NHPs), with case-fatality rates ranging from 23% to 90%.

213 eported worldwide and associated with a high case fatality rate, reinforcing the need for strongly co

214 African American women also have case fatality rates related to preeclampsia 3 times high

215 ctions that are mild or subclinical, and the case-fatality rate remain largely unanswered.

216 evere malaria in Malaysian Borneo, with high case-fatality rates reported.

217 Case fatality rates showed no significant differences wh

218 The case fatality rate significantly decreased between 2001

219 ribavirin and corticosteroid therapy on the case-fatality rate, stratified by SSI.

220 rge tumors, the decline in the size-specific case fatality rate suggests that improved treatment was

221 ently, many cases were reported with a lower case fatality rate than initial cases.

222 espread in South Africa and carries a higher case fatality rate than previously appreciated.

223 tients under the age of 21 years had a lower case fatality rate than those over the age of 45 years (

224 0,000 EBOV copies per milliliter had a lower case fatality rate than those with 10 million EBOV copie

225 (EBOV), causes lethal hemorrhagic fever with case fatality rates that have exceeded 50% in some outbr

226 (HCPS) is a rodent-borne disease with a high case-fatality rate that is caused by several New World h

227 The high case fatality rate, the ability to bind to receptors in

228 oincident with their geographical origin and case-fatality rate; the latter implicated putative prote

229 Other than the case fatality rate, there were no clear differences in t

230 auses a severe hemorrhagic disease with high case fatality rates; there are no approved vaccines or t

231 provements in hospital care may have reduced case fatality rates though a lack of sufficient data on

232 originated epidemics of acute disease with a case fatality rate thought to vary by age and pregnancy

233 ogress to primary septicaemia have a similar case fatality rate to category BSL 3 and 4 pathogens, su

234 ng that convalescent transfusions reduce the case-fatality rate to 12.5% (range, 7.5%-17.5%), we proj

235 emorrhagic fever in East Asia, with reported case fatality rates up to 30%.

236 re hemorrhagic fever in primates, with human case fatality rates up to 90%.

237 holderia pseudomallei and is associated with case-fatality rates up to 40%.

238 he start of the epidemic, the rolling 14-day case fatality rate was 1.0% and remained at or below thi

239 The overall case fatality rate was 11% but was much higher in patien

240 The estimated case fatality rate was 13.2% (9.8-16.8) for patients you

241 The overall case fatality rate was 29.2%, which declined from 35.4%

242 In contrast, the age-adjusted case fatality rate was 3-fold higher for younger blacks

243 Case fatality rate was 3.1%.

244 AML patients were identified; the induction case fatality rate was 3.7%.

245 The observed 60-day case fatality rate was 30.6%.

246 The overall case fatality rate was 31 percent.

247 Case fatality rate was 37% (55/150).

248 Two patients died, and the calculated case fatality rate was 4.9%.

249 The case fatality rate was 55% (53% for CAP and 57% for NHAP

250 The overall case fatality rate was 57%.

251 od was estimated to be 6 to 12 days, and the case fatality rate was 74%.

252 The Hib-associated case fatality rate was 9.4% (10/106 cases).

253 In this outbreak the case fatality rate was about 67%.

254 Their higher case fatality rate was associated with fewer coronary ar

255 able analyses indicated that the decrease in case fatality rate was consistent across most subgroups.

256 sed compared to immunocompetent persons; the case fatality rate was elevated in both younger (odds ra

257 The case fatality rate was estimated at 74.4% (95% CI, 68.3,

258 ates in males exceeded those in females, but case fatality rate was greater in females.

259 ars; interquartile range, 18-40), the 2-year case fatality rate was high (500 deaths, 16.9%).

260 The case fatality rate was highest for C. difficile (40%), r

261 The case fatality rate was highest in children under five ye

262 However, although case fatality rate was increased among patients admitted

263 The in-hospital case fatality rate was low (0.15%) and relapses were rar

264 te of Oroya fever was 13.8% (123 cases); the case-fatality rate was 0.7%.

265 The overall case-fatality rate was 15%.

266 The overall crude case-fatality rate was 16% (54 of 336) among treated pat

267 diagnosed with 0, 1, 2, and 3 conditions the case-fatality rate was 16, 45, 93, and 154 per 1000, res

268 The overall crude case-fatality rate was 19% (28 of 148) among patients wh

269 The hospital case-fatality rate was 2.7% (95% confidence interval: 1.

270 The overall case-fatality rate was 40%.

271 The overall case-fatality rate was 52%.

272 The case-fatality rate was 90%.

273 The overall case-fatality rate was higher among patients with XDR P.

274 Although the case-fatality rate was lower in the 1990s than in the 19

275 Our observed case-fatality rate was lower than has been reported from

276 Case fatality rates were between 0.25% and 0.33% among h

277 HF case fatality rates were examined.

278 fects of ribavirin and corticosteroid on the case-fatality rate were studied by univariate and multiv

279 Case-fatality rates were 1% for gastroenteritis, 5% for

280 Sepsis case-fatality rates were 13% greater in the winter compa

281 agnosed with 3 conditions, the corresponding case-fatality rates were 168 and 137 per 1000 (relative

282 2000 to April, 2001, were studied and their case-fatality rates were compared with the rates in a pe

283 Case-fatality rates were not significantly different acr

284 lated heart block was associated with a 7.8% case fatality rate, whereas the concomitant presence of

285 cant difference in the age-adjusted hospital case fatality rates with regard to gender and race.

286 l occurring throughout Saudi Arabia at a 38% case fatality rate, with the potential for worldwide spr